Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QSOX1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | GNPAT | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TRIM2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | F2R | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | VWDE | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | TH | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | AC008759.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | STEAP1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | KIAA1024L | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | MXD1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |